AU2003288510A1 - Immunizing fish against viral infection - Google Patents

Immunizing fish against viral infection

Info

Publication number
AU2003288510A1
AU2003288510A1 AU2003288510A AU2003288510A AU2003288510A1 AU 2003288510 A1 AU2003288510 A1 AU 2003288510A1 AU 2003288510 A AU2003288510 A AU 2003288510A AU 2003288510 A AU2003288510 A AU 2003288510A AU 2003288510 A1 AU2003288510 A1 AU 2003288510A1
Authority
AU
Australia
Prior art keywords
viral infection
against viral
fish against
immunizing fish
immunizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003288510A
Other languages
English (en)
Other versions
AU2003288510A8 (en
Inventor
Izhak Bejerano
Ayana Benet
Nissim Chen
Marina Hutoran
Moshe Kotler
Ariel Ronen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ministry Of Agriculture & Rural Development Department Of Fisheries And Aquaculture
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of AU2003288510A8 publication Critical patent/AU2003288510A8/xx
Publication of AU2003288510A1 publication Critical patent/AU2003288510A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00061—Methods of inactivation or attenuation
    • C12N2710/00064—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003288510A 2003-01-01 2003-12-22 Immunizing fish against viral infection Abandoned AU2003288510A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL15377503A IL153775A0 (en) 2003-01-01 2003-01-01 Immunizing fish against viral infection
IL153775 2003-01-01
PCT/IL2003/001097 WO2004061093A1 (en) 2003-01-01 2003-12-22 Immunizing fish against viral infection

Publications (2)

Publication Number Publication Date
AU2003288510A8 AU2003288510A8 (en) 2004-07-29
AU2003288510A1 true AU2003288510A1 (en) 2004-07-29

Family

ID=29798413

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003288510A Abandoned AU2003288510A1 (en) 2003-01-01 2003-12-22 Immunizing fish against viral infection

Country Status (12)

Country Link
US (1) US7351527B2 (enExample)
EP (1) EP1578959B1 (enExample)
JP (2) JP4690049B2 (enExample)
CN (1) CN100535108C (enExample)
AT (1) ATE507286T1 (enExample)
AU (1) AU2003288510A1 (enExample)
DE (1) DE60336927D1 (enExample)
DK (1) DK1578959T3 (enExample)
IL (2) IL153775A0 (enExample)
PL (1) PL209978B1 (enExample)
RU (1) RU2369635C2 (enExample)
WO (1) WO2004061093A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109114B2 (ja) * 2006-02-24 2012-12-26 国立大学法人三重大学 魚類抗体産生の新規検出法
EP2011876B1 (en) * 2006-04-13 2014-11-12 National University Corporation Tokyo University of Marine Science and Technology Dna vaccine for koi herpes virus (khv) disease
JP5567244B2 (ja) * 2006-06-06 2014-08-06 共立製薬株式会社 魚類ストレプトコッカス・ディスガラクティエを抗原とする不活化ワクチン
EP2031065A1 (en) * 2007-08-28 2009-03-04 Université de Liège A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi
RU2010111725A (ru) * 2007-08-28 2011-10-10 Юниверсите Де Льеж (Be) Рекомбинантный герпесвирус кои (khv) или герпесвирус 3 семейства карповых (cyhv-3) и вакцина для профилактики заболевания, вызванного khv/cyhv-3 у cyprinus carpio или cyprinus carpio koi
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
JP5462518B2 (ja) * 2009-04-09 2014-04-02 公益財団法人ヒューマンサイエンス振興財団 抗体精製方法
EP2487241A1 (en) 2011-02-09 2012-08-15 Westfälische Wilhelms-Universität Münster RNAi agents and compositions useful as carp therapeutics
IN2014CN04655A (enExample) * 2011-12-30 2015-09-18 Université de Liège
CA2905257C (en) * 2013-03-15 2022-03-15 Atlantium Technologies Ltd. System and method for inactivation of infectious pancreatic necrosis virus (ipnv) using optimized ultraviolet (uv) light
WO2014185439A1 (ja) * 2013-05-15 2014-11-20 独立行政法人水産総合研究センター コイ科ヘルペスウイルス－２（Ｃｙｐｒｉｎｉｄ ｈｅｒｐｅｓｖｉｒｕｓ－２：ＣｙＨＶ－２）感染症用ワクチンおよびその製造方法、ならびにＣｙＨＶ－２ウイルス製造方法
CN103430936A (zh) * 2013-09-06 2013-12-11 中国水产科学研究院黑龙江水产研究所 一种用于鱼类基因组dna提取的鱼鳍组织的制备方法
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CN104774802B (zh) * 2015-04-27 2017-12-08 上海海洋大学 银鲫鱼背鳍细胞系
RU2640346C1 (ru) * 2016-08-11 2017-12-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Государственный аграрный университет Северного Зауралья" (ФГБОУ ВО ГАУ Северного Зауралья) Способ антиоксидантной защиты мальков карпа
EP3897703A2 (en) 2018-12-21 2021-10-27 Intervet International B.V. Serum free intracellular pathogen vaccine
CA3157405A1 (en) 2019-11-18 2021-05-27 Donald D. EVANS II Lyophilized cake in straight-walled vial

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish

Also Published As

Publication number Publication date
JP2011024584A (ja) 2011-02-10
DK1578959T3 (da) 2011-08-15
AU2003288510A8 (en) 2004-07-29
US7351527B2 (en) 2008-04-01
IL169412A (en) 2011-04-28
WO2004061093A1 (en) 2004-07-22
DE60336927D1 (enExample) 2011-06-09
PL376441A1 (en) 2005-12-27
EP1578959A1 (en) 2005-09-28
IL153775A0 (en) 2003-07-31
JP2006512078A (ja) 2006-04-13
RU2369635C2 (ru) 2009-10-10
RU2005120158A (ru) 2006-01-20
US20060013828A1 (en) 2006-01-19
CN100535108C (zh) 2009-09-02
EP1578959B1 (en) 2011-04-27
PL209978B1 (pl) 2011-11-30
ATE507286T1 (de) 2011-05-15
CN1742083A (zh) 2006-03-01
JP4690049B2 (ja) 2011-06-01

Similar Documents

Publication Publication Date Title
IL153775A0 (en) Immunizing fish against viral infection
WO2004080403A3 (en) Influenza virus vaccine
WO2018140766A3 (en) Porcine coronavirus vaccines
EP1220925B8 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2003011223A3 (en) Immunomodulatory compounds and methods of use thereof
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
ATE426412T1 (de) Adjuvante influenza-vakzine
DK1147117T3 (da) Immunologiske adjuvansforbindelser
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
DE60115051D1 (de) Immunologische adjuvans verbindungen
JP2006512078A5 (enExample)
WO2006071896A3 (en) Epitope-based sars vaccine
SE9903534D0 (sv) Vaccin
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
WO2003103570A3 (en) Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
WO2002009749A3 (en) Respiratory syncytial virus vaccine
UA86405C2 (ru) Способ вакцинации против инфекции семенников, вызванной вирусом бычьей вирусной диареи
DE602004028512D1 (de) Rekombinante vakzine gegen infektion mit dem japanischen enzephalitis-virus äjevü und verfahren davon
WO2002096940A3 (en) Attenuated very virulent infectious bursal disease virus
HUP0402548A2 (hu) Madárembrió-részecskékből álló biomassza vírusantigének előállítására
WO2006098769A3 (en) Multipathogen and monopathogen protection against the bacterial and viral infections associated with biological warfare, cardiac diseases, and cancers
UA62746C2 (en) Emulsion vaccine associated inactivated against newcastle disease, infectious bronchitis of fowls, and syndrome of decreasing egg production-76
UA4626U (uk) Бівалентна інактивована концентрат-вакцина проти інфекційного ринотрахеїту та вірусної діареї великої рогатої худоби
EP0954223A4 (en) Modified live bird polyoma virus in parrots
MY146370A (en) Classical swine fever tissue culture live vaccine virus, the tissue culture method of the same and classical swine fever tissue culture live vaccine comprising the same

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 18, NO 34, PAGE(S) 8928 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, APPLICATION NO. 2003288510, UNDER INID (71) CORRECT THE NAME TO READ YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM; STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT AGRICULTURAL RESEARCH ORGANIZATION, THE VOLCANI CENTER

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase